Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Fox Corporation (FOX) - free report >>
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Fox Corporation (FOX) - free report >>
Image: Bigstock
Best Momentum Stocks to Buy for April 22nd
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, April 22:
Dundee Precious Metals Inc. (DPMLF - Free Report) : This gold mining company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 11.7% over the last 60 days.
Dundee Precious Metals Inc. Price and Consensus
Dundee Precious Metals Inc. price-consensus-chart | Dundee Precious Metals Inc. Quote
Dundee Precious Metals' shares gained 47.3% over the last three months compared with the S&P 500’s decline of 15.7%. The company possesses a Momentum Score of A.
Dundee Precious Metals Inc. Price
Dundee Precious Metals Inc. price | Dundee Precious Metals Inc. Quote
Heron Therapeutics, Inc. (HRTX - Free Report) : This commercial-stage biotechnology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 40% over the last 60 days.
Heron Therapeutics, Inc. Price and Consensus
Heron Therapeutics, Inc. price-consensus-chart | Heron Therapeutics, Inc. Quote
Heron Therapeutics' shares gained 9.6% over the last three months compared with the S&P 500’s decline of 15.7%. The company possesses a Momentum Score of A.
Heron Therapeutics, Inc. Price
Heron Therapeutics, Inc. price | Heron Therapeutics, Inc. Quote
Fox Corporation (FOX - Free Report) : This news, sports, and entertainment company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.8% over the last 60 days.
Fox Corporation Price and Consensus
Fox Corporation price-consensus-chart | Fox Corporation Quote
Fox Corporation's shares gained 15.0% over the last six months compared with the S&P 500’s decline of 11.1%. The company possesses a Momentum Score of B.
Fox Corporation Price
Fox Corporation price | Fox Corporation Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.